CARE vs JPM
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Aug 23, 2026
CARE
59.8
AI Score
VS
CARE Wins
JPM
50.7
AI Score
Investment Advisor Scores
JPM
51score
Recommendation
HOLD
AI Analyst Insights
AI insights temporarily unavailable
Detailed Metrics Comparison
| Metric | CARE | JPM | Winner |
|---|---|---|---|
| Revenue | 20.32M | 182.45B | JPM |
| Net Income | 31.36M | 57.00B | JPM |
| Net Margin | 154.4% | 31.2% | CARE |
| ROE | 7.5% | 15.7% | JPM |
| ROA | 0.6% | 1.3% | JPM |
| Total Assets | 4.85B | 4.42T | JPM |
Relative Price Performance (Last 90 Days)
CARE 1M: -7.8%
· 3M: +16.0%
JPM 1M: +0.5%
· 3M: +16.0%
Current Technical Phase
CARE
NeutralHold
Mixed signals - no dominant trend phase, RSI 40
JPM
NeutralHold
Mixed signals - no dominant trend phase, RSI 49
Fundamentals Snapshot
| Metric | CARE | JPM |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 12.1 | 14.1 |
| Trailing P/E | 5.3 | 15.3 |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.7% | 0.3% |
| Gross Margin | 1.0% | 1.0% |
| Operating Margin | 0.6% | 0.5% |
| EPS | 5.80 | 22.96 |
| Dividend Yield | 0.00% | 0.02% |
Frequently Asked Questions
Based on our detailed analysis, CARE is currently the stronger investment candidate, winning 1 of the key financial metrics based on our comprehensive scoring model.
We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.
Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.